Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2020

01-12-2020 | Obesity | Research

Changes of serum retinol-binding protein 4 associated with improved insulin resistance after laparoscopic sleeve gastrectomy in Chinese obese patients

Authors: Xingchun Wang, Yueye Huang, Jingyang Gao, Hang Sun, Muthukumaran Jayachandran, Shen Qu

Published in: Diabetology & Metabolic Syndrome | Issue 1/2020

Login to get access

Abstract

Background

Serum retinol-binding protein 4 (RBP4) plays a critical role in insulin resistance. The mechanism behind the impact of laparoscopic sleeve gastrectomy (LSG) on glucose metabolism is unclear. Hence, we aimed to investigate the triangle relationship between the RBP4, glucose metabolism, and LSG in patients of Chinese ethnicity.

Methods

The study enrolled eighty-two obese patients. Glucose-lipid metabolic index, uric acid (UA), superoxide dismutase (SOD), free triiodothyronine (FT3), free thyroxin (FT4) and thyrotropin (TSH) were measured. RBP4 levels were detected by enzyme-link immunosorbent assay. 30 obese patients underwent LSG were studied. All these markers were measured again at a time interval of 3 and 6 months after surgery.

Results

(1) Circulating RBP4 levels were positively associated with body mass index(BMI), blood glucose in 0 min (BG0), BG30, BG120, BG180, fasting inulin(FINS), fasting C peptide(FCP), homeostasis model of assessment for insulin resistance index (HOMA-IR), SOD, TSH and negatively associated with Matsuda index in obesity with a significant difference (P < 0.05). RBP4 levels in the patients with impaired fasting glucose (IFG), insulin resistance or hyperinsulinemia were significantly higher than the patients without IFG, insulin resistance or hyperinsulinemia (P = 0.035, P = 0.001, and P = 0.007). (2) LSG resulted in significantly decreased FBG, FINS, FCP and HOMA-IR at 3, 6 months after surgery (all P < 0.05). The RBP4 levels were significantly decreased after surgery (all P < 0.05) with no gender difference. (3) The change in RBP4 levels was significantly associated with the change in FINS, FCP, HOMA-IR, and HOMA-β at 6 months and the change in TSH at 3 months after surgery in males (all P < 0.05). The change in RBP4 levels were significantly associated with the change in FINS, FCP, HOMA-IR, HOMA-β, and TCH at 3 months after surgery in females (all P < 0.05).

Conclusions

Overall, our results interpret the significant correlations between RBP4, glucose-lipid metabolism, oxidative stress and thyroid function in obese patients. Further, the LSG brings a decline in RBP4 levels and that may contribute partly to the improved insulin resistance in obese Chinese patients.
Literature
1.
go back to reference Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162(16):1867–72.CrossRef Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162(16):1867–72.CrossRef
2.
go back to reference Li TY, Rana JS, Manson JE, Willett WC, Stampfer MJ, Colditz GA, Rexrode KM, Hu FB. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation. 2006;113(4):499–506.CrossRef Li TY, Rana JS, Manson JE, Willett WC, Stampfer MJ, Colditz GA, Rexrode KM, Hu FB. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation. 2006;113(4):499–506.CrossRef
3.
go back to reference Riobo Servan P. Obesity and diabetes. Nutr Hosp. 2013;28(Suppl 5):138–43. Riobo Servan P. Obesity and diabetes. Nutr Hosp. 2013;28(Suppl 5):138–43.
4.
go back to reference Shoar S, Saber AA. Long-term and midterm outcomes of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass: a systematic review and meta-analysis of comparative studies. Surg Obes Related Dis. 2017;13(2):170–80.CrossRef Shoar S, Saber AA. Long-term and midterm outcomes of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass: a systematic review and meta-analysis of comparative studies. Surg Obes Related Dis. 2017;13(2):170–80.CrossRef
5.
go back to reference Magouliotis DE, Tasiopoulou VS, Svokos AA, Svokos KA, Sioka E, Zacharoulis D. Roux-En-Y gastric bypass versus sleeve gastrectomy as revisional procedure after adjustable gastric band: a systematic review and meta-analysis. Obes Surg. 2017;27(5):1365–73.CrossRef Magouliotis DE, Tasiopoulou VS, Svokos AA, Svokos KA, Sioka E, Zacharoulis D. Roux-En-Y gastric bypass versus sleeve gastrectomy as revisional procedure after adjustable gastric band: a systematic review and meta-analysis. Obes Surg. 2017;27(5):1365–73.CrossRef
6.
go back to reference Switzer NJ, Prasad S, Debru E, Church N, Mitchell P, Gill RS. Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review of long-term outcomes. Obes Surg. 2016;26(7):1616–21.CrossRef Switzer NJ, Prasad S, Debru E, Church N, Mitchell P, Gill RS. Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review of long-term outcomes. Obes Surg. 2016;26(7):1616–21.CrossRef
7.
go back to reference Wang Y, Yi XY, Gong LL, Li QF, Zhang J, Wang ZH. The effectiveness and safety of laparoscopic sleeve gastrectomy with different sizes of bougie calibration: a systematic review and meta-analysis. Int J Surg. 2017;49:32–8.CrossRef Wang Y, Yi XY, Gong LL, Li QF, Zhang J, Wang ZH. The effectiveness and safety of laparoscopic sleeve gastrectomy with different sizes of bougie calibration: a systematic review and meta-analysis. Int J Surg. 2017;49:32–8.CrossRef
8.
go back to reference Kotnik P, Fischer-Posovszky P, Wabitsch M. RBP4: a controversial adipokine. Eur J Endocrinol Eur Fed Endocr Soc. 2011;165(5):703–11.CrossRef Kotnik P, Fischer-Posovszky P, Wabitsch M. RBP4: a controversial adipokine. Eur J Endocrinol Eur Fed Endocr Soc. 2011;165(5):703–11.CrossRef
9.
go back to reference Majerczyk M, Olszanecka-Glinianowicz M, Puzianowska-Kuznicka M, Chudek J. Retinol-binding protein 4 (RBP4) as the causative factor and marker of vascular injury related to insulin resistance. Postepy higieny i medycyny doswiadczalnej. 2016;70:1267–75.PubMed Majerczyk M, Olszanecka-Glinianowicz M, Puzianowska-Kuznicka M, Chudek J. Retinol-binding protein 4 (RBP4) as the causative factor and marker of vascular injury related to insulin resistance. Postepy higieny i medycyny doswiadczalnej. 2016;70:1267–75.PubMed
10.
go back to reference Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005;436(7049):356–62.CrossRef Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005;436(7049):356–62.CrossRef
11.
go back to reference Cheng J, Li Y, Wu G, Zheng J, Lu H, Shi X, Yang G. Ectopic expression of RBP4 impairs the insulin pathway and inguinal fat deposition in mice. J Physiol Biochem. 2014;70(2):479–86.CrossRef Cheng J, Li Y, Wu G, Zheng J, Lu H, Shi X, Yang G. Ectopic expression of RBP4 impairs the insulin pathway and inguinal fat deposition in mice. J Physiol Biochem. 2014;70(2):479–86.CrossRef
12.
go back to reference Jia W, Wu H, Bao Y, Wang C, Lu J, Zhu J, Xiang K. Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab. 2007;92(8):3224–9.CrossRef Jia W, Wu H, Bao Y, Wang C, Lu J, Zhu J, Xiang K. Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab. 2007;92(8):3224–9.CrossRef
13.
go back to reference Liu Y, Wang D, Li D, Sun R, Xia M. Associations of retinol-binding protein 4 with oxidative stress, inflammatory markers, and metabolic syndrome in a middle-aged and elderly Chinese population. Diabetol Metab Syndr. 2014;6(1):25.CrossRef Liu Y, Wang D, Li D, Sun R, Xia M. Associations of retinol-binding protein 4 with oxidative stress, inflammatory markers, and metabolic syndrome in a middle-aged and elderly Chinese population. Diabetol Metab Syndr. 2014;6(1):25.CrossRef
14.
go back to reference Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, Ludvik B. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab. 2007;92(3):1168–71.CrossRef Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, Ludvik B. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab. 2007;92(3):1168–71.CrossRef
15.
go back to reference Silvestre V, Ruano M, García-Lescún MC, Aguirregoicoa E, Criado L, Rodríguez A, Marco A, García-Blanch G. Morbid obesity, non-alcoholic fatty liver disease, metabolic syndrome and bariatric surgery. Nutr Hosp. 2007;22(5):602–6.PubMed Silvestre V, Ruano M, García-Lescún MC, Aguirregoicoa E, Criado L, Rodríguez A, Marco A, García-Blanch G. Morbid obesity, non-alcoholic fatty liver disease, metabolic syndrome and bariatric surgery. Nutr Hosp. 2007;22(5):602–6.PubMed
16.
go back to reference Tschoner A, Sturm W, Engl J, Kaser S, Laimer M, Laimer E, Weiss H, Patsch JR, Ebenbichler CF. Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss. Obesity. 2008;16(11):2439–44.CrossRef Tschoner A, Sturm W, Engl J, Kaser S, Laimer M, Laimer E, Weiss H, Patsch JR, Ebenbichler CF. Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss. Obesity. 2008;16(11):2439–44.CrossRef
17.
go back to reference Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29(5):1130–9.CrossRef Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29(5):1130–9.CrossRef
18.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.CrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.CrossRef
19.
go back to reference Henríquez S, Jara N, Bunout D, Hirsch S, de la Maza MP, Leiva L, Barrera G. Variability of formulas to assess insulin sensitivity and their association with the Matsuda index. Nutr Hosp. 2013;28(5):1594–8.PubMed Henríquez S, Jara N, Bunout D, Hirsch S, de la Maza MP, Leiva L, Barrera G. Variability of formulas to assess insulin sensitivity and their association with the Matsuda index. Nutr Hosp. 2013;28(5):1594–8.PubMed
20.
go back to reference Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26(11):3160–7.CrossRef Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26(11):3160–7.CrossRef
21.
go back to reference Back Giuliano Ide C, Caramelli B, Pellanda L, Duncan B. I Guidelines of prevention of atherosclerosis in childhood and adolescence. Arquivos brasileiros de cardiologia. 2005;85(Suppl 6):4–36.PubMed Back Giuliano Ide C, Caramelli B, Pellanda L, Duncan B. I Guidelines of prevention of atherosclerosis in childhood and adolescence. Arquivos brasileiros de cardiologia. 2005;85(Suppl 6):4–36.PubMed
22.
go back to reference Lee DC, Lee JW, Im JA. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metab Clin Exp. 2007;56(3):327–31.CrossRef Lee DC, Lee JW, Im JA. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metab Clin Exp. 2007;56(3):327–31.CrossRef
23.
go back to reference Aeberli I, Biebinger R, Lehmann R, L’allemand D, Spinas GA, Zimmermann MB. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. J Clin Endocrinol Metab. 2007;92(11):4359–65.CrossRef Aeberli I, Biebinger R, Lehmann R, L’allemand D, Spinas GA, Zimmermann MB. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. J Clin Endocrinol Metab. 2007;92(11):4359–65.CrossRef
24.
go back to reference Reinehr T, Stoffel-Wagner B, Roth CL. Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss. J Clin Endocrinol Metab. 2008;93(6):2287–93.CrossRef Reinehr T, Stoffel-Wagner B, Roth CL. Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss. J Clin Endocrinol Metab. 2008;93(6):2287–93.CrossRef
25.
go back to reference Lu HY, Li XF, Mu PW, Jiang W, Zeng LY. Depot-specific expression of retinol-binding protein 4 in human adipose tissue and their relationship with obesity and insulin resistance. Zhonghua yi xue za zhi. 2010;90(48):3395–8.PubMed Lu HY, Li XF, Mu PW, Jiang W, Zeng LY. Depot-specific expression of retinol-binding protein 4 in human adipose tissue and their relationship with obesity and insulin resistance. Zhonghua yi xue za zhi. 2010;90(48):3395–8.PubMed
26.
go back to reference Friebe D, Neef M, Erbs S, Dittrich K, Kratzsch J, Kovacs P, Blüher M, Kiess W, Körner A. Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children. Int J Pediatr Obes. 2011;6(2–2):e345–52.CrossRef Friebe D, Neef M, Erbs S, Dittrich K, Kratzsch J, Kovacs P, Blüher M, Kiess W, Körner A. Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children. Int J Pediatr Obes. 2011;6(2–2):e345–52.CrossRef
27.
go back to reference Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 2006;354(24):2552–63.CrossRef Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 2006;354(24):2552–63.CrossRef
28.
go back to reference Jüllig M, Yip S, Xu A, Smith G, Middleditch M, Booth M, Babor R, Beban G, Murphy R. Lower fetuin-A, retinol binding protein 4 and several metabolites after gastric bypass compared to sleeve gastrectomy in patients with type 2 diabetes. PLoS ONE. 2014;9(5):e96489.CrossRef Jüllig M, Yip S, Xu A, Smith G, Middleditch M, Booth M, Babor R, Beban G, Murphy R. Lower fetuin-A, retinol binding protein 4 and several metabolites after gastric bypass compared to sleeve gastrectomy in patients with type 2 diabetes. PLoS ONE. 2014;9(5):e96489.CrossRef
29.
go back to reference Kim IK, Lee HJ, Kang JH, Song J. Relationship of serum retinol-binding protein 4 with weight status and lipid profile among Korean children and adults. Eur J Clin Nutr. 2011;65(2):226–33.CrossRef Kim IK, Lee HJ, Kang JH, Song J. Relationship of serum retinol-binding protein 4 with weight status and lipid profile among Korean children and adults. Eur J Clin Nutr. 2011;65(2):226–33.CrossRef
30.
go back to reference Comucci EB, Vasques AC, Geloneze B, Calixto AR, Pareja JC, Tambascia MA. Serum levels of retinol binding protein 4 in women with different levels of adiposity and glucose tolerance. Arquivos brasileiros de endocrinologia e metabologia. 2014;58(7):709–14.CrossRef Comucci EB, Vasques AC, Geloneze B, Calixto AR, Pareja JC, Tambascia MA. Serum levels of retinol binding protein 4 in women with different levels of adiposity and glucose tolerance. Arquivos brasileiros de endocrinologia e metabologia. 2014;58(7):709–14.CrossRef
31.
go back to reference Zabetian-Targhi F, Mahmoudi MJ, Rezaei N, Mahmoudi M. Retinol binding protein 4 in relation to diet, inflammation, immunity, and cardiovascular diseases. Adv Nutr. 2015;6(6):748–62.CrossRef Zabetian-Targhi F, Mahmoudi MJ, Rezaei N, Mahmoudi M. Retinol binding protein 4 in relation to diet, inflammation, immunity, and cardiovascular diseases. Adv Nutr. 2015;6(6):748–62.CrossRef
32.
go back to reference Li F, Yang T, Zhao Z, Xia K. Plasma level of RBP4 in patients with coronary heart disease and the effect of hyperinsulinemia. Zhong nan da xue xue bao Yi xue ban = J Central South Univ Med Sci. 2012;37(11):1177–82. Li F, Yang T, Zhao Z, Xia K. Plasma level of RBP4 in patients with coronary heart disease and the effect of hyperinsulinemia. Zhong nan da xue xue bao Yi xue ban = J Central South Univ Med Sci. 2012;37(11):1177–82.
33.
go back to reference Portmann L, Giusti V. Obesity and hypothyroidism: myth or reality? Revue medicale suisse. 2007;3(105):859–62.PubMed Portmann L, Giusti V. Obesity and hypothyroidism: myth or reality? Revue medicale suisse. 2007;3(105):859–62.PubMed
34.
go back to reference Wang X, Liu H, Chen J, Huang Y, Li L, Rampersad S, Qu S. Metabolic characteristics in obese patients complicated by mild thyroid hormone deficiency. Horm Metab Res. 2016;48(5):331–7.CrossRef Wang X, Liu H, Chen J, Huang Y, Li L, Rampersad S, Qu S. Metabolic characteristics in obese patients complicated by mild thyroid hormone deficiency. Horm Metab Res. 2016;48(5):331–7.CrossRef
35.
go back to reference Güdücü N, Görmüş U, Kavak ZN, İşçi H, Yiğiter AB, Dünder İ. Retinol-binding protein 4 is elevated and is associated with free testosterone and TSH in postmenopausal women. J Endocrinol Invest. 2013;36(10):831–4.PubMed Güdücü N, Görmüş U, Kavak ZN, İşçi H, Yiğiter AB, Dünder İ. Retinol-binding protein 4 is elevated and is associated with free testosterone and TSH in postmenopausal women. J Endocrinol Invest. 2013;36(10):831–4.PubMed
36.
go back to reference Kokkinos S, Papazoglou D, Zisimopoulos A, Papanas N. Retinol binding protein-4 and adiponectin levels in thyroid overt and subclinical dysfunction. Exp Clin Endocrinol Diabetes. 2016;124(2):87–92.PubMed Kokkinos S, Papazoglou D, Zisimopoulos A, Papanas N. Retinol binding protein-4 and adiponectin levels in thyroid overt and subclinical dysfunction. Exp Clin Endocrinol Diabetes. 2016;124(2):87–92.PubMed
37.
go back to reference Kokkinos S, Papazoglou D, Zisimopoulos A, Papanas N, Tiaka E, Antonoglou C, Maltezos E. Changes in oxidative stress and insulin resistance in morbidly obese patients after bariatric surgery. Obes Surg. 2010;20(3):363–8.CrossRef Kokkinos S, Papazoglou D, Zisimopoulos A, Papanas N, Tiaka E, Antonoglou C, Maltezos E. Changes in oxidative stress and insulin resistance in morbidly obese patients after bariatric surgery. Obes Surg. 2010;20(3):363–8.CrossRef
38.
go back to reference Laferrere B. Bariatric surgery and obesity: influence on the incretins. Int J Obes Suppl. 2016;6(Suppl 1):S32–6.CrossRef Laferrere B. Bariatric surgery and obesity: influence on the incretins. Int J Obes Suppl. 2016;6(Suppl 1):S32–6.CrossRef
39.
go back to reference Smith EP, Polanco G, Yaqub A, Salehi M. Altered glucose metabolism after bariatric surgery: what’s GLP-1 got to do with it? Metab Clin Exp. 2017;83:159–66.CrossRef Smith EP, Polanco G, Yaqub A, Salehi M. Altered glucose metabolism after bariatric surgery: what’s GLP-1 got to do with it? Metab Clin Exp. 2017;83:159–66.CrossRef
Metadata
Title
Changes of serum retinol-binding protein 4 associated with improved insulin resistance after laparoscopic sleeve gastrectomy in Chinese obese patients
Authors
Xingchun Wang
Yueye Huang
Jingyang Gao
Hang Sun
Muthukumaran Jayachandran
Shen Qu
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2020
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-019-0511-1

Other articles of this Issue 1/2020

Diabetology & Metabolic Syndrome 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine